Advertisement
Screener

ALSERES PHARMACEUTICALS INC /DE Revenue

ALSERES PHARMACEUTICALS INC /DE Revenue

ALSERES PHARMACEUTICALS INC /DE reported Revenue of $18.43 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.

Discontinued › Income Statement

us-gaap:Revenues · last filed 2014-08-14

  • ALSERES PHARMACEUTICALS INC /DE revenues for the quarter ending 2014-06-30 was $18.43K, a 0.00% change year-over-year.
  • ALSERES PHARMACEUTICALS INC /DE revenues for the quarter ending 2014-03-31 was $18.43K, a 0.00% change year-over-year.
  • ALSERES PHARMACEUTICALS INC /DE revenues for the quarter ending 2013-12-31 was $418.43K, a 2170.15% increase year-over-year.
  • ALSERES PHARMACEUTICALS INC /DE revenues for the quarter ending 2013-09-30 was $18.43K, a 50.00% increase year-over-year.
  • ALSERES PHARMACEUTICALS INC /DE revenues for fiscal 2013 was $473.73K, a 10.74% decline from fiscal 2012.
  • ALSERES PHARMACEUTICALS INC /DE revenues for fiscal 2012 was $530.72K.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 monthRevenues 224 monthRevenues 227 monthRevenues 230 monthRevenues 233 monthRevenues 236 monthRevenues 239 monthRevenues 242 monthRevenues 245 monthRevenues 248 monthRevenues 251 monthRevenues 254 month
2014-06-30$18.43K
10-Q · filed 2014-08-14
$36.86K
10-Q · filed 2014-08-14
$455.30K
derived: sum of 3 quarters · filed 2014-08-14
$473.73K
derived: sum of 4 quarters · filed 2014-08-14
2014-03-31$18.43K
10-Q · filed 2014-05-23
$436.87K
derived: sum of 2 quarters · filed 2014-05-23
$455.30K
derived: sum of 3 quarters · filed 2014-05-23
$473.73K
derived: sum of 4 quarters · filed 2014-08-14
2013-12-31$418.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-10
$436.87K
derived: sum of 2 quarters · filed 2014-04-10
$455.30K
derived: sum of 3 quarters · filed 2014-08-14
$473.73K
10-K · filed 2014-04-10
$1.90M
10-K · filed 2014-04-10
2013-09-30$18.43K
10-Q · filed 2013-11-14
$36.86K
derived: sum of 2 quarters · filed 2014-08-14
$55.30K
10-Q · filed 2013-11-14
$73.73K
derived: sum of 4 quarters · filed 2014-08-14
$1.49M
10-Q · filed 2013-11-14
2013-06-30$18.43K
10-Q · filed 2014-08-14
$36.86K
10-Q · filed 2014-08-14
$55.30K
derived: sum of 3 quarters · filed 2014-08-14
$67.58K
derived: sum of 4 quarters · filed 2014-08-14
$1.47M
10-Q · filed 2013-08-09
2013-03-31$18.43K
10-Q · filed 2014-05-23
$36.86K
derived: sum of 2 quarters · filed 2014-05-23
$49.15K
derived: sum of 3 quarters · filed 2014-05-23
$299.15K
derived: sum of 4 quarters · filed 2014-05-23
$1.45M
10-Q · filed 2013-05-17
2012-12-31$18.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-10
$30.72K
derived: sum of 2 quarters · filed 2014-04-10
$280.72K
derived: sum of 3 quarters · filed 2014-04-10
$530.72K
10-K · filed 2014-04-10
$1.43M
10-K · filed 2013-04-01
2012-09-30$12.29K
10-Q · filed 2013-11-14
$262.29K
derived: sum of 2 quarters · filed 2013-11-14
$512.29K
10-Q · filed 2013-11-14
$1.41M
10-Q · filed 2012-11-14
2012-06-30$250.00K
10-Q · filed 2013-08-09
$500.00K
10-Q · filed 2013-08-09
$1.40M
10-Q · filed 2012-08-13
2012-03-31$250.00K
10-Q · filed 2013-05-17
$1.15M
10-Q · filed 2012-05-11
2011-12-31$900.00K
10-K · filed 2012-03-29
2011-09-30$900.00K
10-Q · filed 2011-11-10
2011-06-30$900.00K
10-Q · filed 2011-08-11